PuSH - Publikationsserver des Helmholtz Zentrums München

18 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Kiefer, L.S.* et al.: Distribution patterns of intramyocellular and extramyocellular fat by magnetic resonance imaging in subjects with diabetes, prediabetes and normoglycaemic controls. Diabetes Obes. Metab. 23, 1868–1878 (2021)
2.
Sachs, S. et al.: Plasma proteome profiles treatment efficacy of incretin dual agonism in diet-induced obese female and male mice. Diabetes Obes. Metab. 23, 195-207 (2021)
3.
Seufert, J.* et al.: Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety. Diabetes Obes. Metab., DOI: 10.1111/dom.14549 (2021)
4.
Mathieu, C.* et al.: Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index >= 27 kg/m(2). Diabetes Obes. Metab. 22, 2151-2160 (2020)
5.
Pfohl, M.* et al.: Effectiveness and safety of insulin glargine 300 U/mL in insulin-naive patients with type 2 diabetes after failure of oral therapy in a real-world setting. Diabetes Obes. Metab. 22, 759-766 (2020)
6.
Brede, S.* et al.: Intranasal oxytocin fails to acutely improve glucose metabolism in obese men. Diabetes Obes. Metab. 21, 424-428 (2019)
7.
Jendle, J.* et al.: Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials. Diabetes Obes. Metab., DOI: 10.1111/dom.13816 (2019)
8.
Plomgaard, P.* et al.: Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels. Diabetes Obes. Metab. 21, 993-1000 (2019)
9.
Kantartzis, K. et al.: Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Obes. Metab. 20, 1793-1797 (2018)
10.
McCreight, L.* et al.: Pharmacokinetics of metformin in patients with gastrointestinal intolerance. Diabetes Obes. Metab. 20, 1593-1601 (2018)
11.
Schmid, V. et al.: Safety of intranasal human insulin: A review. Diabetes Obes. Metab. 20, 1563-1577 (2018)
12.
Clemmensen, C. ; Jørgensen, C.V.* ; Smajilovic, S.* & Bräuner-Osborne, H.*: Robust GLP-1 secretion by basic L-amino acids does not require the GPRC6A receptor. Diabetes Obes. Metab. 19, 599-603 (2017)
13.
Müller, A. ; Mziaut, H. ; Neukam, M. ; Knoch, K.-P. & Solimena, M.: A 4D view on insulin secretory granule turnover in the β-cell. Diabetes Obes. Metab. 19, 107-114 (2017)
14.
Klement, J.* ; Mergelkuhl, B.* ; Born, J. ; Lehnert, H.* & Hallschmid, M.: Role of γ-aminobutyric acid signalling in the attenuation of counter-regulatory hormonal responses after antecedent hypoglycaemia in healthy men. Diabetes Obes. Metab. 16, 1274-1278 (2014)
15.
Klement, J.* et al.: NMDA receptor blockade by memantine does not prevent adaptation to recurrent hypoglycaemia in healthy men. Diabetes Obes. Metab. 15, 310-315 (2013)
16.
Herzberg-Schäfer, S.* ; Heni, M.* ; Stefan, N. ; Häring, H.-U. & Fritsche, A.: Impairment of GLP1-induced insulin secretion: Role of genetic background, insulin resistance and hyperglycaemia. Diabetes Obes. Metab. 14, S3, 85-90 (2012)
17.
Liu, Y.* ; Mziaut, H.* ; Ivanova, A.* & Solimena, M.*: beta-Cells at the crossroads: Choosing between insulin granule production and proliferation. Diabetes Obes. Metab. 11, 54-64 (2009)
18.
Marrett, E.* ; Stargardt, T. ; Mavros, P.* & Alexander, C.M.*: Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: Associations with hypoglycaemia and weight gain. Diabetes Obes. Metab. 11, 1138-1144 (2009)